Abstracts Archive - Page 337 of 1683 - ATC Abstracts

2020 American Transplant Congress
Incidence of Skin Cancer – A Long Term Outcome of Immunosuppression in Renal Transplant Recipients Associated with the Usage of Azathioprine
H. Bheemreddy¹, S. Yusuf¹, N. Krishnan², A. Imtiaz³
¹Health and Life Sciences, Coventry University, Coventry, United Kingdom, ²Renal Unit, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom, ³Department of Dermatology, University Hospital Coventry and Warwickshire NHS Trust, Coventry, United Kingdom
*Purpose: The main cause of mortality in Kidney Transplant Recipient’s (KTRs) is malignancy. The cancer incidence is increased by treating with immunosuppressive agents and longer…
2020 American Transplant Congress
Evaluation of Cytomegalovirus Prophylaxis in Low and Intermediate Risk Kidney Transplant Recipients Receiving Lymphocyte-Depleting Induction
H. Stamps, K. Linder, D. O'Sullivan, F. Cheema, H. Kutzler
Hartford Hospital, Hartford, CT
*Purpose: This study evaluates if choice and duration of Cytomegalovirus (CMV) prophylaxis based on donor (D) and recipient (R) CMV serostatus impacts the incidence of…
2020 American Transplant Congress
The Level of Plasm Donor-Derived Cell-Free DNA in Kidney Transplant Patients with Severe Pneumonia
L. Liu¹, H. Liu², F. Liu², L. Shu², L. Peng¹
¹Xiangyang Hospital No. 2 of Central South University, Changsha, China, ²AlloDx, Shanghai; Suzhou, China
*Purpose: Pulmonary infection is one of the common complications after kidney transplantation. Donor-derived cell-free DNA (ddcfDNA) is a new biomarker to diagnose allograft injury. Currently,…
2020 American Transplant Congress
Incidence and Outcomes of Secondary Cutaneous Malignancies among Renal Transplant Recipients
T. Maw¹, P. Vaidya¹, J. Samaan², S. Ghanshani¹, G. In¹
¹Keck School of Medicine, LA, CA, ²Cedar Sinai Hospital, LA, CA
*Purpose: Solid-organ transplant recipients on immunosuppressive therapy are known to have higher morbidity and mortality from secondary malignancies; however, there are no established guidelines for…
2020 American Transplant Congress
Cytomegalovirus Preemptive Monitoring Conversion and the Use of a Preemptive Threshold after Solid Organ Transplant
C. Wong, M. Jorgenson, J. Descourouez, C. Saddler, J. Smith, D. Mandelbrot
UWHC, Madison, WI
*Purpose: Cytomegalovirus (CMV) in solid organ transplant (SOT) is associated with negative graft and patient outcomes. Prophylactic agents of choice have substantial cytotoxicity, and patients…
2020 American Transplant Congress
The Centennial Allograft – Can an Organ Function for Over 100 Years in 2 Different Individuals?
A. Gruessner, J. Renz, S. Saggi, R. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: We investigated the occurrence of deceased-donor liver (DDOLT), deceased-donor renal (DDRT), and living-donor renal allografts (LDRT) that have achieved or come close to 100…
2020 American Transplant Congress
The Association of Body Weight Gain/Change and Hepatocellular Carcinoma Recurrence after Liver Transplant
O. Ahmed¹, M. Sauer¹, N. Vachharajani¹, S. H. Chang², Y. Park², A. S. Khan¹, W. C. Chapman¹, M. B. Doyle¹
¹Department of Surgery, Washington University School of Medicine, St Louis, MO, ²Division of Public Health Sciences, Washington University School of Medicine, St Louis, MO
*Purpose: Functional recovery in liver transplant recipients is commonly confounded by weight changes relating to various aspects of liver disease such as cachexia, ascites and…
2020 American Transplant Congress
Vira-ome: A Tool for an Unbiased Plasma Virome Analysis of SOT Recipients from Cell-Free DNA Sequences
R. Sinha, E. Bixler, J. Grantham, M. Altrich, S. Kleiboeker
R&D, Viracor-Eurofins, Lee's Summit, MO
*Purpose: Blood virome of healthy individuals is frequently predominated by member of families such as Herpesvirus, Anellovirus and Polyomaviridae. The viral load of commensal species…
2020 American Transplant Congress
Risk of Infectious Complications after GastroIntestinal Surgery in Renal Transplant Recipients
S. Karhadkar, P. Jacoby, T. Webster, A. Di Carlo
Temple University School of Medicine, Philadelphia, PA
*Purpose: Solid organ transplantation remains the preferred treatment for patients with end stage organ diseases. In 2018 alone, 36, 527 organ transplants were performed in…
2020 American Transplant Congress
The Oncological Optimal Tacrolimus Target Level after Liver Transplant for Hepatocellular Carcinoma
K. Sasaki¹, J. McVey¹, D. Firl², Y. Inaba³, C. D. Kwon¹, K. Hashimoto¹, F. Aucejo¹
¹The Cleveland Clinic, Cleveland, OH, ²Duke University, Durham, NC, ³Chiba University, Chiba, Japan
*Purpose: The recurrence rate after liver transplant (LT) for hepatocellular carcinoma (HCC) is high as 15-20% nevertheless of complete removal of tumor and carcinogenic liver.…